Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

Kentaro Hayashida; Thierry Lefèvre

doi:10.4244/EIJV8SQA8

Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

Kentaro Hayashida, Thierry Lefèvre

Department of Internal Medicine (Cardiology)

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

Significant aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) has been shown to be associated with worse mid-term outcome. The two-year follow-up results of the PARTNER US trial showed that not only ≥3/4 AR grade, but also grade 2 had a significant impact on mortality. Thus, prevention and treatment of significant AR after TAVI is of great importance. Usually, AR after TAVI consists mostly of paravalvular leak and significant central AR is uncommon. Here we describe measures to decrease the risk of AR after TAVI which are currently available.

Original language	English
Pages (from-to)	Q34-Q40
Journal	EuroIntervention
Volume	8
DOIs	https://doi.org/10.4244/EIJV8SQA8
Publication status	Published - 2012 Jan 1

Keywords

Aortic regurgitation
TAVI

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.4244/EIJV8SQA8

Fingerprint Dive into the research topics of 'Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation'. Together they form a unique fingerprint.

Cite this

@article{875638cf3a3f4fccac7ec6484749a90f,

title = "Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation",

abstract = "Significant aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) has been shown to be associated with worse mid-term outcome. The two-year follow-up results of the PARTNER US trial showed that not only ≥3/4 AR grade, but also grade 2 had a significant impact on mortality. Thus, prevention and treatment of significant AR after TAVI is of great importance. Usually, AR after TAVI consists mostly of paravalvular leak and significant central AR is uncommon. Here we describe measures to decrease the risk of AR after TAVI which are currently available.",

keywords = "Aortic regurgitation, TAVI",

author = "Kentaro Hayashida and Thierry Lef{\`e}vre",

year = "2012",

month = jan,

day = "1",

doi = "10.4244/EIJV8SQA8",

language = "English",

volume = "8",

pages = "Q34--Q40",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

}

TY - JOUR

T1 - Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

AU - Hayashida, Kentaro

AU - Lefèvre, Thierry

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Significant aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) has been shown to be associated with worse mid-term outcome. The two-year follow-up results of the PARTNER US trial showed that not only ≥3/4 AR grade, but also grade 2 had a significant impact on mortality. Thus, prevention and treatment of significant AR after TAVI is of great importance. Usually, AR after TAVI consists mostly of paravalvular leak and significant central AR is uncommon. Here we describe measures to decrease the risk of AR after TAVI which are currently available.

AB - Significant aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) has been shown to be associated with worse mid-term outcome. The two-year follow-up results of the PARTNER US trial showed that not only ≥3/4 AR grade, but also grade 2 had a significant impact on mortality. Thus, prevention and treatment of significant AR after TAVI is of great importance. Usually, AR after TAVI consists mostly of paravalvular leak and significant central AR is uncommon. Here we describe measures to decrease the risk of AR after TAVI which are currently available.

KW - Aortic regurgitation

KW - TAVI

UR - http://www.scopus.com/inward/record.url?scp=84894368966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894368966&partnerID=8YFLogxK

U2 - 10.4244/EIJV8SQA8

DO - 10.4244/EIJV8SQA8

M3 - Review article

C2 - 22995110

AN - SCOPUS:84894368966

VL - 8

SP - Q34-Q40

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

ER -

Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this